Condition

Dry Age-related Macular Degeneration clinical trials and research

• 8Clinical trials
• 3Countries

Newest Dry Age-related Macular Degeneration clinical trials

All recruiting trials (8)

• OCU410 for Geographic Atrophy due to Dry AMD: treatment to help the eye

  A Phase 3 trial tests whether a single subretinal injection of OCU410 can help people 55 and older with geographic atrophy from dry AMD.

  Recruiting Phase 3 Ocugen · Phoenix, Arizona and 2 other locations · NCT07770828

• PathFinder 1.0 detects retinal abnormalities on macular OCT scans

  This study tests PathFinder 1.0's ability to find retinal issues on macular OCT scans in adults.

  Recruiting at 5 sites Carl Zeiss Meditec-Dublin CoCe · Tucson, Arizona and 5 other locations · NCT07680244

• Subretinal CPCB-RPE1 implant for advanced dry AMD with geographic atrophy

  This trial will try a surgical CPCB-RPE1 implant in one eye to see if it is safe and helps people aged 55–90 with advanced dry AMD and geographic atrophy that involves the fovea.

  Recruiting at 5 sites Phase 2 Regenerative Patch Technologies, LLC · Huntington Beach, California and 4 other locations · NCT06557460

• Treatment for dry age-related macular degeneration using umbilical cord blood plasma

  This study is testing if injections of umbilical cord blood plasma can help older adults with dry age-related macular degeneration slow down or improve their vision.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Rome, Rome · NCT06536062

• Registry to assess light therapy for dry age-related macular degeneration

  This study is testing if a new light therapy can safely help people with dry age-related macular degeneration see better.

  Recruiting LumiThera, Inc. · Beverly Hills, California and 5 other locations · NCT06351605

• Treatment for dry age-related macular degeneration using umbilical cord blood platelet-rich plasma injections

  This study is testing if injections of umbilical cord blood platelets can help older adults with dry age-related macular degeneration keep their vision from getting worse.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Rome · NCT05706896

• Transplanting stem cells to treat dry age-related macular degeneration

  This study is testing a new stem cell treatment for people with dry age-related macular degeneration to see if it is safe and well-tolerated.

  Recruiting at 3 sites Phase 1/2 Luxa Biotechnology, LLC · Beverly Hills, California and 2 other locations · NCT04627428

• Transplanting stem cells to treat vision loss from age-related macular degeneration

  This study is testing if transplanting special stem cells into the eyes of older adults with vision loss from age-related macular degeneration can help improve their eyesight.

  Recruiting Phase 1/2 National Institutes of Health Clinical Center (CC) · Baltimore, Maryland and 1 other locations · NCT04339764

Related topics

Quick answers

How many Dry Age-related Macular Degeneration clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United States (6 trials), Italy (2 trials), Norway (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 2, Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →